An update from Savara ( (SVRA) ) is now available.

Savara Inc. (NASDAQ:SVRA) is one of the top long-term biotechnology stocks to buy. On October 2, Savara Inc. (NASDAQ:SVRA) announced that its partner, TrilliumBiO, will present data on the development ...

SAVARA ($SVRA) is expected to release its quarterly earnings data on Wednesday, April 2nd after market close, per Finnhub. Analysts are expecting revenue of $0 and ...

A look at the shareholders of Savara Inc. (NASDAQ:SVRA) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 37% ownership. In other words, ...

Savara Inc. (NASDAQ:SVRA) is one of the best stocks under $5 with highest upside potential. On October 23, Citizens JMP lifted its price target on Savara Inc. (NASDAQ:SVRA) to $11 from $8 while ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Savara (SVRA – Research Report) today and set a price target of $7.00. The company’s shares closed yesterday at $4.24. Bayko covers the ...

In a report released today, Francois Brisebois from Oppenheimer maintained a Buy rating on Savara (SVRA – Research Report), with a price target of $15.00. The company’s shares closed yesterday at ...

NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: ...

HC Wainwright reaffirmed their buy rating on shares of Savara (NASDAQ:SVRA – Free Report) in a research note published on Friday,Benzinga reports. HC Wainwright currently has a $6.00 price objective ...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...